Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 2, 2026

Mizuho resets view on Snowflake stock after CRO change

View original at finance.yahoo.com
Mizuho resets view on Snowflake stock after CRO change Snowflake (SNOW) stock is starting to look interesting again. Shares are down about 30% this year while the company has just appointed a new chief revenue officer as it tries to reaccelerate growth and improve sales execution…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • JB has been a key driver of our success for the past ten years, and has consistently proven his ability to deliver results at scale

    60% confidence
  • Mizuho sees over 40% upside for Snowflake stock with $220 price target

    60% confidence
  • The next question is whether Q1 results show stable pipeline trends and continued customer expansion under the new CRO

    60% confidence
  • Product revenue growth in the second half of FY2026 coming in lighter than expected

    60% confidence
  • A leadership change introduces near-term risks to pipeline continuity, deal timing, and expansion motion, just as the company tries to turn product momentum into usage growth

    60% confidence
  • JB has been a key driver of Snowflake's success for the past ten years and has consistently proven his ability to deliver results at scale

    60% confidence
  • Leadership change introduces near-term risks to pipeline continuity, deal timing, and expansion motion, just as the company tries to turn product momentum into usage growth

    60% confidence
  • Mizuho sees over 40% upside for Snowflake stock with $220 price target

    60% confidence

Data points we hold from this source

Snowflake Inc. · analyst target price239 USD
Snowflake Inc. · enterprise value50 USD
Snowflake Inc. · forward pe ratio84.3 ratio
Snowflake Inc. · implied upside55 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
Mizuho resets view on Snowflake stock after CRO change — Source | Via News | Via News